Gilead
  • Contact
  • |
  • Sitemap
  • |
  • About
    • Senior Management
    • Worldwide Operations
    • Ethics
    • Business Conduct
    • Business Partnerships
    • Corporate History Timeline
  • Medicines
    • Request Information
    • Consumer Product Safety Improvement Act
    • Authorized Distributors of Record
    • Product Approval Timeline
    • Anti-Counterfeiting
  • Research
    • Pipeline
    • Clinical Trials
    • Investigator Sponsored Research
    • Conquering Hepatitis via Micro-Elimination
    • Expanded Access
  • Responsibility
    • Gilead COMPASS Initiativeā„¢
    • Year In Review 2016
    • U.S. Patient Access
    • Developing World Access
    • Corporate Contributions
    • Policy Perspectives
    • Gilead Foundation
    • HCV Elimination
    • State Disclosures
    • Supplier Code
  • News
    • Press Releases
    • Company Statements
    • Events
    • Media FAQs
    • Fact Sheets and Infographics
    • Media Inquiries
  • Investors
    • Recent News
    • Corporate Governance
    • Stock Information
    • Financial Information
    • Earnings
    • SEC Filings
    • Shareholder Center
    • Annual Reports
    • E-mail Alerts
    • Investor FAQs
    • Investor Contacts
    • Investor Disclaimer
  • Careers
    • Research Pipeline
    • Our Values
    • Developing World Access
    • Corporate Responsibility
    • U.S. Benefits
    • Inclusion & Diversity
    • Internships

Senior Management

  • Home
  • /
  • About
  • /
  • Senior Management
  • Senior Management
    • John F. Milligan, PhD
    • Gregg H. Alton
    • Andrew Cheng, MD, PhD
    • William A. Lee, PhD
    • John McHutchison, MD
    • Brett Pletcher
    • Alessandro Riva, MD
    • Martin B. Silverstein, MD
    • Robin L. Washington
    • Katie L. Watson
    • Taiyin Yang, PhD
  • Board of Directors
Share

The information in this section is intended for visitors outside the United States.

Continue

  • John F. Milligan, PhD   

    President and Chief Executive Officer

  • Gregg H. Alton   

    Executive Vice President, International Operations and Corporate Affairs

  • Andrew Cheng, MD, PhD   

    Chief Medical Officer, Executive Vice President

  • William A. Lee, PhD   

    Executive Vice President, Research

  • John McHutchison, MD   

    Chief Scientific Officer, Head of Research and Development

  • Brett A. Pletcher   

    Executive Vice President, General Counsel and Chief Compliance Officer

  • Alessandro Riva, MD   

    Executive Vice President, Oncology Therapeutics

  • Martin B. Silverstein, MD   

    Executive Vice President, Strategy

  • Robin L. Washington   

    Executive Vice President and Chief Financial Officer

  • Katie L. Watson   

    Executive Vice President, Human Resources

  • Taiyin Yang, PhD   

    Executive Vice President, Pharmaceutical Development and Manufacturing

  • About Gilead
    • Senior Management
    • Worldwide Operations
    • Ethics
    • Business Conduct
    • Business Partnerships
    • Corporate History Timeline
    Research
    • Pipeline
    • Clinical Trials
    • Investigator Sponsored Research
  • Medicines
    • Request Information
    • Consumer Product Safety
    • Authorized Distributors of Record
    • Product Approval Timeline
  • Responsibility
    • U.S. Patient Access
    • Developing World Access
    • Corporate Contributions
    • Policy Perspectives
    • Gilead Foundation
    News
    • Press Releases
    • Events
    • Media FAQs
    • Fact Sheets
    • Media Inquiries
  • Investors
    • Recent News
    • Corporate Governance
    • Stock Information
    • Financial Information
    • SEC Filings
    • Shareholder Center
    • Annual Reports
    • Email Alerts
    • Investor FAQs
    • Investor Contacts
    • Investor Disclaimer
  • Careers
    • Pipeline
    • Our Values
    • Developing-World-Access
    • Corporate-Contributions
    • U.S. Benefits
© 2009-2016 Gilead. All rights reserved. Terms of Use  |  Privacy Statements
        Product images shown do not represent actual size.